Avid Bioservices Inc (CDMO)

[asmarterwookie]

CRI has had Peregrine on their radar.....

One rule about Peregrine and Bavituximab. Don't talk about Peregrine and Bavituximab.....yet...betcha Bavituximab is part of it.

Participants from industry include Advaxis; Agenus; Amgen; BioNTech; Bristol-Myers Squibb; Genentech, a member of the Roche Group; ISA Pharmaceuticals; MedImmune, the global biologics research and development arm of AstraZeneca; Neon Therapeutics and Personalis, Inc.

The six academic research centers that make up the core of the Parker Institute are also expected to participate, including: Memorial Sloan Kettering Cancer Center, Stanford Medicine, the University of California, Los Angeles (UCLA), the University of California, San Francisco, the University of Pennsylvania and The University of Texas MD Anderson Cancer Center. Initial tissue samples are expected to be provided by Memorial Sloan Kettering Cancer Center, National Cancer Centre Singapore, Roswell Park Cancer Institute, UCLA, the University Hospital of Siena in Italy and the John Theurer Cancer Center at Hackensack University Medical Center, a member of Hackensack Meridian Health. As the project progresses, the alliance will add to its growing roster of participants.

- See more at: http://www.cancerresearch.org/news/2016/PICI-and-CRI-Launch-Collaboration-on-Cancer-Neoantigens#sthash.PamV5RM6.dpuf


imho

wook